| HOME >> BIOLOGY >> TECHNOLOGY |
BOSTON, Sept. 18 /PRNewswire-FirstCall/ -- PAREXEL Consulting, a business unit of PAREXEL International (Nasdaq: PRXL) and a leading global life sciences consultancy serving the bio/pharmaceutical and medical device industries, announced today that it is strengthening its Good Manufacturing Practice (GMP) capabilities in Europe to help its global client base address complexities of European Union (EU) directives in areas such as manufacturing regulations, quality, and safety.
This initiative includes the addition of three senior consultants to the PAREXEL Consulting team based in Europe. Clive Brading, formerly in a senior Corporate Quality Assurance role at Sanofi-Aventis, has been appointed to the position of Director to lead the PAREXEL Consulting European team of experts focused on strategic compliance and operational process excellence. Dr. Ralf Hess, who served as Chief Scientific Officer for HISS Diagnostics GmbH, and Dr. Siegfried Schmitt, previously a global Quality Assurance Director for Amersham Health (now GE Healthcare), have both been appointed to the position of Principal Consultant.
"As biopharmaceutical companies face intensifying safety obligations, rising operational costs, and the complexities of EU regulations and ICH quality guidelines, they need help to proactively and effectively manage these hurdles," said Gadi Saarony, Corporate Vice President and Worldwide Head of PAREXEL Consulting. "We are responding to client needs by expanding our established cadre of GMP experts located in Europe, represented by the appointments of Mr. Brading, Dr. Hess, and Dr. Schmitt."
"Clients rely on our team of specialists for traditional GxP
requirements, but also need help with more contemporar
'/>"/>
| SOURCE PAREXEL International Copyright©2007 PR Newswire. All rights reserved |